Therefore, one of the strategies for gut microbial modulation is oral supplementation with Bifidobacterium spp., which has improved tumor control and enhanced PD-L1 blockade therapy through CD8+ T cell priming and accumulation in the TME [13]. The gene discussed is CD8A; the disease is neoplasm.